Drugs join forces to overcome lung cancer resistance

被引：0
作者：
不详
机构：
来源：
CANCER BIOLOGY & THERAPY | 2009年 / 8卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII / VII
页数：1
相关论文
共 50 条
[31]   The spirituality human dimension as a join forces against cancer [J].
Respini, D. ;
Lissandrello, G. ;
Aragona, M. ;
Tralongo, P. .
PSYCHO-ONCOLOGY, 2006, 15 (02) :S380-S381
[32]   Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model [J].
Knapp, DC ;
Mata, JE ;
Reddy, MT ;
Devi, GR ;
Iversen, PL .
ANTI-CANCER DRUGS, 2003, 14 (01) :39-47
[33]   Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance [J].
Ni, Duan ;
Li, Yun ;
Qiu, Yuran ;
Pu, Jun ;
Lu, Shaoyong ;
Zhang, Jian .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (05) :336-348
[34]   Platinum drugs and taxanes: can we overcome resistance? [J].
Elena V. Sazonova ;
Gelina S. Kopeina ;
Evgeny N. Imyanitov ;
Boris Zhivotovsky .
Cell Death Discovery, 7
[35]   Platinum drugs and taxanes: can we overcome resistance? [J].
Sazonova, Elena V. ;
Kopeina, Gelina S. ;
Imyanitov, Evgeny N. ;
Zhivotovsky, Boris .
CELL DEATH DISCOVERY, 2021, 7 (01)
[36]   Mechanisms of resistance to EGFR-targeted drugs: lung cancer [J].
Morgillo, Floriana ;
Della Corte, Carminia Maria ;
Fasano, Morena ;
Ciardiello, Fortunato .
ESMO OPEN, 2016, 1 (03)
[37]   Save the Children and GSK join forces to develop drugs for children in developing countries [J].
Mayor, Susan .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[38]   Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer [J].
Tong, Christy W. S. ;
Wu, William K. K. ;
Loong, Herbert H. F. ;
Cho, William C. S. ;
To, Kenneth K. W. .
CANCER LETTERS, 2017, 405 :100-110
[39]   Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer [J].
Vyse, Simon ;
Howitt, Annie ;
Huang, Paul H. .
JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (12) :1767-1786
[40]   Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer [J].
Cao, Lin ;
Qin, Zhiyan ;
Yu, Ting ;
Bai, Xupeng ;
Jiang, Shiqin ;
Wang, Daifei ;
Ning, Fangqing ;
Huang, Min ;
Jin, Jing .
BIOCHEMICAL PHARMACOLOGY, 2024, 224
12345